Skip to main content
. 2015 Aug 25;6:878. doi: 10.3389/fmicb.2015.00878

Figure 1.

Figure 1

PARP inhibition decreases HIV-1 reverse transcriptase (RT) activity and HIV-1 LTR activity in HIV-1 infected human macrophages (MDM). RT activity assays performed on HIV-infected MDM treated with PARPi or AZT either for 24 h prior to HIV infection (A) or immediately after (B) HIV infection. Treatments with PARP inhibitors (PARPi) or AZT were replenished every 12 h. The results are shown as the mean value ± SEM from three independent experiments utilizing MDM prepared from different donors. Data are presented as percent of HIV-only control. (**p = 0.05, ***p = 0.005, ****p < 0.0001, ns = not significant).